DU
Delphia (USA) Portfolio holdings
AUM
$445K
This Quarter Return
-16.08%
1 Year Return
+28.83%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$145M
AUM Growth
+$145M
(+8.9%)
Cap. Flow
+$30.6M
Cap. Flow
% of AUM
21.06%
Top 10 Holdings %
Top 10 Hldgs %
11.34%
Holding
533
New
208
Increased
130
Reduced
42
Closed
153
Top Buys
| 1 |
McDonald's
MCD
|
$1.1M |
| 2 |
H&R Block
HRB
|
$1.08M |
| 3 |
Amazon
AMZN
|
$979K |
| 4 |
Mastercard
MA
|
$974K |
| 5 |
Delek US
DK
|
$937K |
Top Sells
| 1 |
Occidental Petroleum
OXY
|
$1.11M |
| 2 |
Phillips 66
PSX
|
$1.09M |
| 3 |
APA Corp
APA
|
$1.02M |
| 4 |
EQT Corp
EQT
|
$961K |
| 5 |
Vistra
VST
|
$777K |
Sector Composition
| 1 | Technology | 19.22% |
| 2 | Healthcare | 18.31% |
| 3 | Consumer Discretionary | 13.71% |
| 4 | Industrials | 8.71% |
| 5 | Financials | 8.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AVYA
326
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
| $127K | 0.09% |
+56,830
| New | +$127K |
|
|
TWOU
327
DELISTED
2U, Inc.
TWOU
| $123K | 0.08% |
+11,752
| New | +$123K |
|
328
Traeger
COOK
$170M
| $122K | 0.08% |
+28,626
| New | +$122K |
|
329
ImmunityBio
IBRX
$2.25B
| $118K | 0.08% |
31,709
+6,205
| +24% | +$23.1K |
|
330
Yext
YEXT
$1.1B
| $117K | 0.08% |
+24,538
| New | +$117K |
|
331
ADT
ADT
$7.04B
| $114K | 0.08% |
+18,538
| New | +$114K |
|
332
Generation Bio
GBIO
$40.3M
| $111K | 0.08% |
+16,850
| New | +$111K |
|
|
BDN
333
Brandywine Realty Trust
BDN
$736M
| $109K | 0.08% |
+11,292
| New | +$109K |
|
|
CTT
334
DELISTED
CATCHMARK TIMBER TRUST, INC.
CTT
| $108K | 0.07% |
+10,702
| New | +$108K |
|
335
DiamondRock Hospitality
DRH
$1.73B
| $107K | 0.07% |
+13,013
| New | +$107K |
|
|
PRVB
336
DELISTED
Provention Bio, Inc. Common Stock
PRVB
| $103K | 0.07% |
+25,698
| New | +$103K |
|
337
Gossamer Bio
GOSS
$589M
| $100K | 0.07% |
+11,935
| New | +$100K |
|
338
CarParts.com
PRTS
$48.5M
| $99K | 0.07% |
+14,295
| New | +$99K |
|
339
Advantage Solutions
ADV
$564M
| $95K | 0.07% |
25,043
+15,007
| +150% | +$56.9K |
|
340
Sutro Biopharma
STRO
$80.6M
| $95K | 0.07% |
+18,140
| New | +$95K |
|
341
Protagonist Therapeutics
PTGX
$3.66B
| $94K | 0.06% |
+11,845
| New | +$94K |
|
342
Western New England Bancorp
WNEB
$257M
| $91K | 0.06% |
+12,160
| New | +$91K |
|
343
Macerich
MAC
$4.58B
| $90K | 0.06% |
+10,327
| New | +$90K |
|
344
Ardmore Shipping
ASC
$475M
| $89K | 0.06% |
+12,769
| New | +$89K |
|
345
Crawford & Co Class A
CRD.A
$529M
| $89K | 0.06% |
+11,409
| New | +$89K |
|
346
Century Therapeutics
IPSC
$41.1M
| $89K | 0.06% |
+10,548
| New | +$89K |
|
|
CNSL
347
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
| $89K | 0.06% |
+12,739
| New | +$89K |
|
348
Instil Bio
TIL
$197M
| $88K | 0.06% |
+19,064
| New | +$88K |
|
349
Prelude Therapeutics
PRLD
$64M
| $88K | 0.06% |
+16,940
| New | +$88K |
|
350
Douglas Elliman
DOUG
$230M
| $87K | 0.06% |
+18,236
| New | +$87K |
|